Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aldena Therapeutics

Request full access

Developing therapies for Dermatology, discovering and enabling delivery of nucleic acid therapies in conditions with high burden to patients

Boston, United StatesFounded 2021Biotech & Life Sciences

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
18.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B
Investment activity
5 companies, latest Feb 2024
Capital deployed
—
Preferred round
MERGER

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
MERGER✓Other financing Feb 2024 $0 — Graegis Pharmaceuticals · Granular Therapeutics · Klirna Biotech · Nira Biosciences ↗
EARLY VC✓Equity / VC Mar 2023 $30M $120M Medicxi ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Aldena Therapeutics team growth

Aldena Therapeutics's team grew 20% over the past year.

1-year team growth+20%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Aldena Therapeutics in the Boston ecosystem

Live from Dealroom

The Aldena Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Medicxi

Other known investors6 additional known investors

  • Graegis Pharmaceuticals
  • Granular Therapeutics
  • Klirna Biotech
  • Nira Biosciences
  • Vimela Therapeutics
  • Alys Pharmaceuticals
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇭 Switzerland50%
🇺🇸 United States50%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aldena Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aldena Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.